SEC 13F Intelligence

Boxer Capital, LLC / ESPR

Boxer Capital, LLC’s Esperion Therapeutics Inc Ne Position

Does Boxer Capital, LLC own Esperion Therapeutics Inc Ne (ESPR)? Not currently — the last reported position was 500.0K shares worth $11M in Q2 2021; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$11M
Q2 2021
Shares
500.0K
% of Portfolio
+0.37%
Quarters Held
11
position exited

Position History ESPR

Reported value by quarter
Q4 ’18: $55MQ4 ’18Q1 ’19: $39MQ2 ’19: $45MQ2 ’19Q3 ’19: $36MQ4 ’19: $58MQ4 ’19Q1 ’20: $31MQ2 ’20: $50MQ2 ’20Q3 ’20: $36MQ4 ’20: $13MQ4 ’20Q1 ’21: $14MQ2 ’21: $11MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021500.0K$11M+0.37%
Q1 2021500.0K$14M+0.48%
Q4 2020500.0K$13M+0.42%
Q3 2020975.0K$36M+1.25%
Q2 2020975.0K$50M+2.20%
Q1 2020975.0K$31M+2.10%
Q4 2019975.0K$58M+3.29%
Q3 2019975.0K$36M+2.59%
Q2 2019975.0K$45M+3.90%
Q1 2019975.0K$39M+4.53%
Q4 20181.20M$55M+6.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of ESPR.